Toxicity of intravesical gemcitabine in superficial bladder cancer treatment

Toxicity of intravesical gemcitabine in superficial bladder cancer treatment

Bibliographic Details
Main Authors:	R. Gavira Moreno, P. Beardo Villar, R. Gamaza Martínez
Format:	Article
Language:	English
Published:	Grupo Aula Médica 2014-05-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/646.pdf

Similar Items

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
by: Thiru Prasanna, et al.
Published: (2017-11-01)

Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation
by: Karavana SY, et al.
Published: (2018-07-01)

Management of BCG non-responders with fixed dose intravesical gemcitabine in superficial transitional cell carcinoma of urinary bladder
by: N K Mohanty, et al.
Published: (2008-01-01)

Is single-dose postoperative intravesical gemcitabine effective to prevent recurrence in patients with non-muscle invasive bladder cancer?
by: Abhishek Jain, et al.
Published: (2010-01-01)

Intravesical electrophoresis of doxorubicin for superficial bladder cancer. Results of prospective randomized trial
by: A. I. Rolevich, et al.
Published: (2020-02-01)

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
by: Tian-Wei Wang, et al.
Published: (2019-10-01)

Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer
by: S. Lukacs, et al.
Published: (2013-01-01)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
by: Uyen To, et al.
Published: (2014-01-01)

Intravesical application of Gemicitabine for superficial bladder cancer resistant to intrvesical immunotherapy with BCG vaccine
by: I. V. Seregin, et al.
Published: (2020-02-01)

Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan–thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers
by: Ay Şenyiğit Z, et al.
Published: (2015-10-01)

Is the calcified lesion of bladder wall after intravesical mitomycin-c therapy for superficial bladder cancer should be resected?
by: Jing-Dung Shen, et al.
Published: (2015-06-01)

Phase I/II Pilot Study of Intravesical Apaziquone (EO9) for Superficial Bladder Cancer
by: Puri, Rajiv, et al.
Published: (2009)

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
by: Richmond A. Owusu, et al.
Published: (2013-01-01)

Disseminated Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder
by: Fatehi Elzein, et al.
Published: (2016-09-01)

The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study
by: Pawan Vasudeva, et al.
Published: (2008-01-01)

INTRAVESICAL THERAPY FOR BLADDER CANCER: STATE-OF-THE ART
by: V. V. Protoshchak, et al.
Published: (2014-08-01)

INTRAVESICAL THERAPY FOR BLADDER CANCER: STATE-OF-THE ART
by: V. V. Protoshchak, et al.
Published: (2014-08-01)

Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial
by: Rongxin Li, et al.
Published: (2020-07-01)

Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model
by: Zhengwen Xiao, et al.
Published: (2011-01-01)

17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer
by: C. W. Cheng, et al.
Published: (2005-06-01)

The efficacy and safety of intravesical gemcitabine vs Bacille Calmette-Guérin for adjuvant treatment of non-muscle invasive bladder cancer: a meta-analysis
by: Ye Z, et al.
Published: (2018-08-01)

What have we learned after 30 years of BCG intravesical therapy for superficial bladder cancer?
by: Marcos Tobias-Machado, et al.
Published: (2009-12-01)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
by: Jan-Friedrich Jokisch, et al.
Published: (2015-01-01)

The Use of Polymer Chitosan in Intravesical Treatment of Urinary Bladder Cancer and Infections
by: Andreja Erman, et al.
Published: (2018-03-01)

RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy
by: Zhenxing Yang, et al.
Published: (2019-07-01)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
by: Sima P Porten, et al.
Published: (2015-01-01)

Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder
by: Fatehi Elzein, et al.
Published: (2016-08-01)

Evaluating the need for transurethral bladder biopsy at first follow up after intravesical BCG therapy for superficial bladder cancer: Preliminary data
by: K. Mursi, et al.
Published: (2012-03-01)

Gemcitabine (Citochem) in the treatment of advanced transitional cell bladder cancer
by: V. B. Matveyev, et al.
Published: (2020-02-01)

The synergy of gemcitabine with clusterin antisense oligonucleotides in the treatment of bladder cancer
by: Glackin, A. J.
Published: (2005)

Arteriovenous Hemangioma of the Urinary Bladder Following Intravesical Treatment
by: Ali Sarıbacak, et al.
Published: (2011-09-01)

High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
by: Mekayten M, et al.
Published: (2018-05-01)

Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma of the bladder
by: Michael S. Cookson, et al.
Published: (2014-10-01)

Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies
by: Jin X, et al.
Published: (2016-09-01)

Intravesical ureterocele masquerading as bladder tumor
by: Suresh Bhat, et al.
Published: (2002-01-01)

Intravesical therapy for urothelial carcinoma of the bladder
by: M Manoharan
Published: (2011-01-01)

Ten years′ experience with adjuvant intravesical immunotherapy in management of superficial transitional cell carcinoma of urinary bladder - a review
by: N K Mohanty, et al.
Published: (2001-01-01)

Intravesical electrical stimulation treatment for overactive bladder: An observational study
by: J. Joshua Yune, et al.
Published: (2018-07-01)

INTRAVESICAL BCG THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
by: K. M. Figurin
Published: (2014-07-01)

INTRAVESICAL BCG THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
by: K. M. Figurin
Published: (2014-07-01)